134 related articles for article (PubMed ID: 7983603)
21. Clopidogrel does not affect the pharmacokinetics of theophylline.
Caplain H; Thebault JJ; Necciari J
Semin Thromb Hemost; 1999; 25 Suppl 2():65-8. PubMed ID: 10440427
[TBL] [Abstract][Full Text] [Related]
22. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
[TBL] [Abstract][Full Text] [Related]
23. Sustained release properties of the once daily theophylline capsule BY912 as compared with Theo-24 capsules.
Jonkman JH; Steinijans VW; Beier W; van der Boon WJ; Crasmeijer G
Biopharm Drug Dispos; 1989; 10(2):213-24. PubMed ID: 2706320
[TBL] [Abstract][Full Text] [Related]
24. Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing.
Goldenheim PD; Conrad EA; Schein LK
Chronobiol Int; 1987; 4(3):397-408. PubMed ID: 3315269
[TBL] [Abstract][Full Text] [Related]
25. Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers.
Vincent J; Teng R; Dogolo LC; Willavize SA; Friedman HL
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():81-6. PubMed ID: 9222075
[TBL] [Abstract][Full Text] [Related]
26. Multicenter comparison of once-daily Uniphyl tablets administered in the morning or evening with baseline twice-daily theophylline therapy in patients with nocturnal asthma.
Grossman J
Am J Med; 1988 Jul; 85(1B):11-3. PubMed ID: 3041821
[TBL] [Abstract][Full Text] [Related]
27. Night-time pharmacokinetics of once a day theophylline: a steady state comparison of three preparations.
Karttunen P; Tukiainen H; Nykänen S; Saano V
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):161-5. PubMed ID: 3997302
[TBL] [Abstract][Full Text] [Related]
28. Chronotherapy of reversible airways disease with once-daily evening doses of a controlled-release theophylline preparation.
Goldenheim PD; Schein LK
Ann N Y Acad Sci; 1991; 618():490-503. PubMed ID: 2006803
[TBL] [Abstract][Full Text] [Related]
29. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
30. Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration.
Steinijans VW; Trautmann H; Sauter R; Staudinger H
Arzneimittelforschung; 1988 Aug; 38(8A):1251-3. PubMed ID: 3190814
[TBL] [Abstract][Full Text] [Related]
31. Circadian variation in steady-state trough theophylline concentrations.
Reed RC; Schwartz HJ
Ther Drug Monit; 1986; 8(2):155-60. PubMed ID: 3726928
[TBL] [Abstract][Full Text] [Related]
32. Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation.
Rivington RN; Calcutt L; Child S; MacLeod JP; Hodder RV; Stewart JH
Am J Med; 1985 Dec; 79(6A):67-72. PubMed ID: 4083303
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
34. Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.
Chrystyn H; Ellis JW; Mulley BA; Peake MD
Br J Clin Pharmacol; 1989 Feb; 27(2):215-21. PubMed ID: 2713215
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
[TBL] [Abstract][Full Text] [Related]
36. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
[TBL] [Abstract][Full Text] [Related]
37. Plasma theophylline concentrations and airway function in asthmatic children receiving standard and modified RTC therapy.
Arakawa H; Morikawa A; Shigeta M; Kato M; Kuroume T; Kimura T; Tateno K
J Asthma; 1992; 29(4):235-43. PubMed ID: 1634448
[TBL] [Abstract][Full Text] [Related]
38. Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.
Hibberd SG; Alveyn C; Coombes EJ; Holgate ST
Br J Clin Pharmacol; 1986 Sep; 22(3):337-41. PubMed ID: 3768245
[TBL] [Abstract][Full Text] [Related]
39. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
40. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.
Arkinstall WW; Atkins ME; Harrison D; Stewart JH
Am Rev Respir Dis; 1987 Feb; 135(2):316-21. PubMed ID: 3813191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
